{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "1794",
                "1797"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ASD"
        },
        {
            "identifier": "T2",
            "position": [
                "1812",
                "1832"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zabiegu operacyjnego"
        },
        {
            "identifier": "T3",
            "position": [
                "1834",
                "1848"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T4",
            "position": [
                "1849",
                "1862"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "identifier": "T5",
            "position": [
                "1865",
                "1882"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergiczny"
        },
        {
            "identifier": "T6",
            "position": [
                "1883",
                "1889"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "ujemny"
        },
        {
            "identifier": "T7",
            "position": [
                "1635",
                "1652"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergiczny"
        },
        {
            "identifier": "T8",
            "position": [
                "1653",
                "1659"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "ujemny"
        },
        {
            "identifier": "T9",
            "position": [
                "1619",
                "1632"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "identifier": "T10",
            "position": [
                "1604",
                "1618"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T11",
            "position": [
                "1580",
                "1601"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badania diagnostyczne"
        },
        {
            "identifier": "T12",
            "position": [
                "1557",
                "1563"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ASD II"
        },
        {
            "identifier": "T13",
            "position": [
                "1342",
                "1409"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w."
        },
        {
            "identifier": "T14",
            "position": [
                "875",
                "941"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w"
        },
        {
            "identifier": "T15",
            "position": [
                "329",
                "336"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Furagin"
        },
        {
            "identifier": "T16",
            "position": [
                "337",
                "358"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "2 x 25 mg przez 5 dni"
        },
        {
            "identifier": "T17",
            "position": [
                "414",
                "437"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "planowej operacji serca"
        },
        {
            "identifier": "T18",
            "position": [
                "626",
                "633"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Furagin"
        },
        {
            "identifier": "T19",
            "position": [
                "636",
                "645"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Midazolam"
        },
        {
            "identifier": "T20",
            "position": [
                "648",
                "657"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "kropl\u00f3wka"
        },
        {
            "identifier": "T21",
            "position": [
                "1103",
                "1112"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T22",
            "position": [
                "1115",
                "1124"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Kropl\u00f3wka"
        },
        {
            "identifier": "T23",
            "position": [
                "947",
                "972"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "\u0141agodna infekcja jelitowa"
        },
        {},
        {
            "identifier": "T24",
            "position": [
                "359",
                "392"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Zg\u0142osi si\u0119 do Kliniki Kardiologii"
        },
        {
            "identifier": "T25",
            "position": [
                "393",
                "410"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "w dniu 09.04.2018"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N2",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N3",
            "referenced": "T5",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N4",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N5",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N6",
            "referenced": "T13",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N7",
            "referenced": "T14",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:A09",
            "identifier": "N8",
            "referenced": "T23",
            "subtype": "Reference",
            "type": "N",
            "value": "Biegunka i zapalenie \u00c5\u00bco\u00c5\u0082\u00c4\u0085dkowo-jelitowe o przypuszczalnie zaka\u00c5\u00banej etiologii"
        },
        {
            "arg1": "T15",
            "arg2": "T16",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T4",
            "arg2": "T3",
            "identifier": "R12",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T6",
            "arg2": "T5",
            "identifier": "R15",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T8",
            "arg2": "T7",
            "identifier": "R25",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T25",
            "arg2": "T24",
            "identifier": "R3",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T9",
            "arg2": "T10",
            "identifier": "R40",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nFuragin 2 x 25 mg przez 5 dni\nZg\u0142osi si\u0119 do Kliniki Kardiologii w dniu 09.04.2018 do planowej operacji serca ( ze skierowaniem od lekarza POZ , po telefonicznym potwierdzeniu ).\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nFuragin , Midazolam , kropl\u00f3wka\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w .\\x0a\u0141agodna infekcja jelitowa .\\x0aQ21.1\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolin , Kropl\u00f3wka\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w.\\x0aQ21.1\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\ndziewczynka z ASD II , skierowana na badania diagnostyczne , lek\u00f3w na sta\u0142e nie otrzymuje , wywiad alergiczny ujemny\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\ndziecko z ASD skierowana do zabiegu operacyjnego, lek\u00f3w na sta\u0142e nie otrzymuje , wywiad alergiczny ujemny\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:6.98[10\\\\^3/ul]\n    RBC:4.54[10\\\\^6/ul]\n    HGB:12.3[g/dl]\n    HCT:34.7[%]\n    MCV:76.4[fl]\n    MCH:27.1[pg]\n    MCHC:35.4[g/dl]\n    PLT:253.0[10\\\\^3/ul]\n    RDW-SD:40.8[fl]\n    RDW-CV:14.6[%]\n    PDW:10.5[fl]\n    MPV:9.7[fl]\n    P-LCR:21.9[%]\n    PCT:0.2[%]\n    NEUTR#:1.80[10\\\\^3/ul]\n    NEUTR%:25.8[%]\n    LYMPH#:4.71[10\\\\^3/ul]\n    LYMPH%:67.5[%]\n    MONO#:0.35[10\\\\^3/ul]\n    MONO%:5.00[%]\n    EO#:0.09[10\\\\^3/ul]\n    EO%:1.30[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nMorfologia\n    WBC:7.60[10\\\\^3/ul]\n    RBC:4.17[10\\\\^6/ul]\n    HGB:11.7[g/dl]\n    HCT:32.3[%]\n    MCV:77.5[fl]\n    MCH:28.1[pg]\n    MCHC:36.2[g/dl]\n    PLT:267.0[10\\\\^3/ul]\n    RDW-SD:40.8[fl]\n    RDW-CV:14.6[%]\n    PDW:10.1[fl]\n    MPV:9.8[fl]\n    P-LCR:23.1[%]\n    PCT:0.3[%]\n    NEUTR#:2.08[10\\\\^3/ul]\n    NEUTR%:27.3[%]\n    LYMPH#:4.99[10\\\\^3/ul]\n    LYMPH%:65.7[%]\n    MONO#:0.45[10\\\\^3/ul]\n    MONO%:5.90[%]\n    EO#:0.06[10\\\\^3/ul]\n    EO%:0.80[%]\n    BASO#:0.02[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Erym:3 /uL \u015bw.[ul]\n    Leum:4 /uL[ul]\n    Bakm:pojedyncze[wpw]\n    NabP\u0142m:pojedyncze[wpw]\n    Pas\u015al:liczny[wpw]\nABL Parametry krytyczne\n    pH:7.359\n    pCO2:40.3[mmHg]\n    BE:-2.60[mmol/L]\n    HCO3:22.1[mmol/L]\n    pO2:44.6[mmHg]\n    O2Sat:75.8[%]\n    Na - ABL:138[mmol/L]\n    K - ABL:3.7[mmol/L]\n    Cl - ABL:107[mmol/L]\n    Ca zj ABL:1.29[mmol/L]\n    Ht - ABL:37.8[%]\n    Hb ABL:12.3[g/dl]\n    FO2Hb:74.6[%]\n    FCOHb:0.9[%]\n    FMetHb:0.7[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:107[mg/dl]\n    mleczany:14[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.388\n    pCO2:30.3[mmHg]\n    BE:-5.70[mmol/L]\n    HCO3:17.9[mmol/L]\n    pO2:60.3[mmHg]\n    O2Sat:91.2[%]\n    Na - ABL:141[mmol/L]\n    K - ABL:3.6[mmol/L]\n    Cl - ABL:110[mmol/L]\n    Ca zj ABL:1.29[mmol/L]\n    Ht - ABL:35.4[%]\n    Hb ABL:11.5[g/dl]\n    FO2Hb:89.9[%]\n    FCOHb:0.9[%]\n    FMetHb:0.5[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:76[mg/dl]\n    mleczany:15[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.409\n    pCO2:37.6[mmHg]\n    BE:-0.50[mmol/L]\n    HCO3:23.3[mmol/L]\n    pO2:66.9[mmHg]\n    O2Sat:93.8[%]\n    Na - ABL:139[mmol/L]\n    K - ABL:4.1[mmol/L]\n    Cl - ABL:108[mmol/L]\n    Ca zj ABL:1.29[mmol/L]\n    Ht - ABL:36.7[%]\n    Hb ABL:11.9[g/dl]\n    FO2Hb:92.4[%]\n    FCOHb:0.9[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:82[mg/dl]\n    mleczany:21[mg/dl]\n    COMMENT_HL7:\nBadanie og\u00f3lne moczu\n    Barwa:jasno\u017c\u00f3\u0142ta\n    Przej:niezupe\u0142na\n    SG:1.009\n    pH:6.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:20 mg/dL[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecne[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:271.0[ng/ml]\nFibrynogen (F): FIB:2.01[g/L]\nFibrynogen (F): FIB:2.14[g/L]\nAntytrombina III (ATIII): ATIII:100.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:28.3[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:27.4[s]\nINR: INR:1.1\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.3[s]\nCzas protrombinowy (PT): PT:12.1[s]\nCzas trombinowy (TT): TT:17.2[s]\nCzas trombinowy (TT): TT:16.9[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:89[%]\nWska\u017anik PT: PT%:91[%]\nKreatynina: CREA:0.30[mg/dl]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:24.00[mg/dl]\nMocznik: UREA:25.00[mg/dl]\nASPAT: AST:44.00[IU/L]\nASPAT: AST:37.00[IU/L]\nALAT: ALT:36.00[IU/L]\nALAT: ALT:28.00[IU/L]\nPLT z morfologii: PLT:253.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:101.00[pg/ml]\nNT- proBNP: NTpBNP:99.70[pg/ml]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:110.1[ml/min/1,73m2]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:140.4[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:80[cm]\nWzrost pacjenta: WzrostPac:102[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:146.7[ml/min/1,73m2]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:187.0[ml/min/1,73m2]\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:nie wykryto\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/001071\n    DONACJA:Z510118000712\n    DONACJA:Z510018005717\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.602\nG21\nG25\n89.541\n------------------------------------------------"
}